Overview Performance Dividends Peer Group Options

(RX) Biosyent - Performance 27.4% in 12m

RX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating 75.12%
#5 in Peer-Group
Rel. Strength 76.44%
#1793 in Stock-Universe
Total Return 12m 27.36%
#33 in Peer-Group
Total Return 5y 148.24%
#13 in Peer-Group
P/E Value
P/E Trailing 17.9
P/E Forward 16.0
High / Low CAD
52 Week High 12.00 CAD
52 Week Low 9.06 CAD
Sentiment Value
VRO Trend Strength +-100 86.34
Buy/Sell Signal +-5 -0.32
Support / Resistance Levels
Support
Resistance
12m Total Return: RX (27.4%) vs XLV (-5.1%)
Total Return of Biosyent versus its related sector ETF XLV
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (RX) Biosyent - Performance 27.4% in 12m

Top Performer in Pharmaceuticals

Short Term Performance

Symbol 1w 1m 3m
RX -0.33% 11.1% 6.79%
PHAT 20.5% 206% 120%
VTYX 0.0% 112% 81.6%
ALTS 3.27% 64.1% 127%

Long Term Performance

Symbol 6m 12m 5y
RX 1.05% 27.4% 148%
ALTS 172% 335% 234%
VRNA 116% 453% 1,673%
BGM 57.0% 276% -72.2%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
CORT NASDAQ
Corcept Therapeutics		 -4.5% 145% 360% 61.3 55.3 0.61 23.7% -5.15%
LLY NYSE
Eli Lilly		 12% -6.78% 514% 66.1 37 1.24 58.2% 18.9%
NVS NYSE
Novartis		 10.1% 17.9% 81.6% 18.5 14 1.37 8.70% 9.2%
NOVN SW
Novartis		 7.55% 7.58% 54.8% 18.7 14.1 1.38 9.80% 11.2%
SFZN SW
Siegfried Holding		 -0.63% 2.28% 140% 26.1 25 1.48 77.8% 77.6%
GSK NYSE
GlaxoSmithKline		 10% 4.92% 57.7% 19.9 9.2 0.4 -25.2% 3.11%
AZN NASDAQ
AstraZeneca		 9.51% -4.27% 58.6% 28.9 15.9 0.96 52.7% 22.3%
IPN PA
Ipsen		 2.14% -13% 54.2% 24.4 10.3 0.74 -6.40% -6.33%

Performance Comparison: RX vs XLV vs S&P 500

XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RX
Total Return (including Dividends) RX XLV S&P 500
1 Month 11.06% 4.35% 1.11%
3 Months 6.79% -6.89% 5.58%
12 Months 27.36% -5.08% 10.51%
5 Years 148.24% 50.53% 109.12%

Trend Score (consistency of price movement) RX XLV S&P 500
1 Month 60.2% 65.8% 69.9%
3 Months 55.3% -72% 69.3%
12 Months 59.5% -62.2% 43.2%
5 Years 78.1% 88.5% 84.1%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XLV vs. S&P 500
1 Month #55 6.43% 9.84%
3 Month #68 14.70% 1.15%
12 Month #33 34.17% 15.25%
5 Years #11 64.91% 18.71%

FAQs

Does Biosyent (RX) outperform the market?

Yes, over the last 12 months RX made 27.36%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%. Over the last 3 months RX made 6.79%, while XLV made -6.89%.

Performance Comparison RX vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

RX vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 0.1% 10% 2% 17%
US NASDAQ 100 QQQ 0.4% 9.6% 2.8% 18%
German DAX 40 DAX 2.3% 11.8% -14.3% -2%
Shanghai Shenzhen CSI 300 CSI 300 0.4% 12% 0.2% 16%
Hongkong Hang Seng HSI -0.4% 6% -17% -0%
India NIFTY 50 INDA 1.8% 12.4% 3.1% 29%
Brasil Bovespa EWZ -2.2% 10.6% -18.2% 18%

RX vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 0.5% 9.6% -0.8% 5%
Consumer Discretionary XLY 0.7% 12.9% 11.9% 10%
Consumer Staples XLP 0.4% 11.3% 0.6% 20%
Energy XLE -5.8% 8.2% -1.6% 24%
Financial XLF 1.7% 13.6% -0.8% 4%
Health Care XLV -1.8% 6.7% 2.5% 32%
Industrial XLI 1.2% 10.7% -3.5% 9%
Materials XLB 0.8% 9.7% 1.3% 28%
Real Estate XLRE -0.4% 10.1% 1.1% 14%
Technology XLK -0.2% 9.1% 1.7% 23%
Utilities XLU -1.3% 10.5% -6.3% 6%
Aerospace & Defense XAR 1.1% 5.3% -14.9% -15%
Biotech XBI 0.5% 3.3% 12.8% 35%
Homebuilder XHB 1.7% 16.1% 17.5% 37%
Retail XRT 4% 11.2% 10% 27%

RX vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -11.7% -7.63% -7.80% 24%
Natural Gas UNG 0.9% 13.7% -16.2% 42%
Gold GLD -3.5% 4.9% -28.1% -20%
Silver SLV 0.9% -0.3% -17.6% 5%
Copper CPER 2.6% 9.4% -12.8% 19%

RX vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -1.4% 10.4% 3.5% 31%
iShares High Yield Corp. Bond HYG -0.4% 10.6% -1.6% 18%